Skip to main content
TipRanks
Go Ultimate75% OFF

Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD) Ratios

24 Followers

Hong Kong Pharma Digital Technology Holdings Ltd. Ratios

HKPD's free cash flow for Q4 2026 was $-507.62K. For the 2026 fiscal year, HKPD's free cash flow was decreased by $-37.00 and operating cash flow was $-507.58K. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio3.862.992.461.08
Quick Ratio3.752.802.161.00
Cash Ratio0.070.260.200.21
Solvency Ratio-0.140.240.510.61
Operating Cash Flow Ratio-0.240.20-0.120.68
Short-Term Operating Cash Flow Coverage-0.861.53-1.8327.70
Net Current Asset Value$ 9.07M$ 4.30M$ 3.39M$ -73.05K
Leverage Ratios
Debt-to-Assets Ratio0.100.250.240.20
Debt-to-Equity Ratio0.130.480.491.18
Debt-to-Capital Ratio0.120.320.330.54
Long-Term Debt-to-Capital Ratio0.000.230.210.17
Financial Leverage Ratio1.341.892.045.82
Debt Service Coverage Ratio-0.322.447.8520.28
Interest Coverage Ratio-7.461.3519.4344.91
Debt to Market Cap0.070.190.060.01
Interest Debt Per Share1.180.270.290.06
Net Debt to EBITDA-3.261.350.580.09
Profitability Margins
Gross Profit Margin10.32%11.89%21.32%21.81%
EBIT Margin-7.48%0.66%9.64%8.31%
EBITDA Margin-2.37%5.94%15.19%14.01%
Operating Profit Margin-7.41%0.65%9.64%8.31%
Pretax Profit Margin-8.40%0.18%9.14%8.13%
Net Profit Margin-8.46%-0.13%7.97%7.95%
Continuous Operations Profit Margin-8.46%-0.13%7.97%7.95%
Net Income Per EBT100.68%-74.92%87.14%97.79%
EBT Per EBIT113.41%27.35%94.88%97.79%
Return on Assets (ROA)-8.84%-0.29%15.34%29.30%
Return on Equity (ROE)-11.85%-0.54%31.26%170.56%
Return on Capital Employed (ROCE)-10.31%2.03%29.29%121.84%
Return on Invested Capital (ROIC)-9.18%-1.34%22.10%79.97%
Return on Tangible Assets-8.90%-0.29%15.40%29.34%
Earnings Yield-8.50%-0.28%6.40%3.22%
Efficiency Ratios
Receivables Turnover3.544.314.497.40
Payables Turnover7.8310.369.927.01
Inventory Turnover33.4531.9614.0751.43
Fixed Asset Turnover30.9434.2120.0219.19
Asset Turnover1.052.161.933.69
Working Capital Turnover Ratio1.803.896.920.00
Cash Conversion Cycle67.4260.8770.504.38
Days of Sales Outstanding103.1584.6981.3349.35
Days of Inventory Outstanding10.9111.4225.957.10
Days of Payables Outstanding46.6435.2336.7852.08
Operating Cycle114.0696.11107.2856.45
Cash Flow Ratios
Operating Cash Flow Per Share-0.640.06-0.050.16
Free Cash Flow Per Share-0.670.05-0.070.15
Dividend Paid and CapEx Coverage Ratio-21.193.67-4.4814.67
Capital Expenditure Coverage Ratio-21.193.67-4.4814.67
Operating Cash Flow Coverage Ratio-0.600.24-0.192.50
Operating Cash Flow to Sales Ratio-0.060.03-0.020.14
Free Cash Flow Yield-5.89%4.25%-2.32%5.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-11.72-400.0015.6231.08
Price-to-Sales (P/S) Ratio0.990.481.242.47
Price-to-Book (P/B) Ratio1.391.954.8853.00
Price-to-Free Cash Flow (P/FCF) Ratio-16.9723.52-43.0619.27
Price-to-Operating Cash Flow Ratio-17.7817.12-52.6717.96
Price-to-Earnings Growth (PEG) Ratio-0.013.940.160.00
Enterprise Value Multiple-45.309.428.7717.73
Enterprise Value14.40M11.37M22.24M31.19M
EV to EBITDA-45.309.428.7717.73
EV to Sales1.070.561.332.48
EV to Free Cash Flow-18.2927.45-46.1019.38
EV to Operating Cash Flow-19.1519.97-56.3918.06
Tangible Book Value Per Share8.090.540.570.05
Shareholders’ Equity Per Share8.160.550.580.05
Tax and Other Ratios
Effective Tax Rate-0.011.750.130.02
Revenue Per Share11.432.252.271.14
Net Income Per Share-0.97-0.000.180.09
Tax Burden1.01-0.750.870.98
Interest Burden1.120.270.950.98
Research & Development to Revenue0.000.000.000.00
SG&A to Revenue0.180.110.000.00
Stock-Based Compensation to Revenue0.000.000.000.00
Income Quality0.66-21.04-0.301.73

Currency in USD